dpp-4 inhibitor and glp-1 receptor agonist combination not recommended guideline The Role of Inhibitors in the Treatment Algorithm of Type 2 Diabetes Mellitus: When to Select, What to Expect Safety of SGLT2 inhibitors, DPP-4

Multi-factorial risk scoring incorporates patient factors, medication characteristics, and procedural requirements to stratify patients into low, moderate, and high-risk categories [54]

Assessing the effectiveness of community-based substance abuse treatment for adolescents

Emerging mechanisms of glutathione-dependent chemistry in biology and disease

Takahashi H, Lassmann T, Murata M, Carninci P

Semaglutide features a substitution of alanine residue with a non-coded amino acid, 2-aminoisobutyric acid (Aib) at position 8, shielding against DPP-4-mediated N-terminal proteolysis while preserving GLP-1R affinity (96)

Di FilippoMMarcaisCCharriereSMarmontelOBroyerMDelayMet alPost-heparin LPL activity measurement using VLDL as a substrate: a new robust method for routine assessment of plasma triglyceride lipolysis defects